Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. It operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
Company Information
About this company
Key people
Thomas E. Polen
Chairman of the Board, President, Chief Executive Officer
Vitor Roque
Interim Chief Financial Officer
Shana Carol Neal
Chief People Officer, Executive Vice President
Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Richard Byrd
Executive Vice President, President - Interventional Segment
Michael Feld
Executive Vice President, President - Life Sciences
Michael Garrison
Executive Vice President, President - Medical Segment
Roland Goette
Executive Vice President, President - EMEA
Pavan Mocherla
Executive Vice President, President - Greater Asia
Bilal Muhsin
Executive Vice President, President - Connected Care Segment
Bertram L. Scott
Lead Independent Director
William M. Brown
Independent Director
Carrie L. Byington
Independent Director
Robert Andrew Eckert
Independent Director
Gregory J. Hayes
Independent Director
Click to see more
Key facts
- Shares in issue370.59m
- EPICBDX
- ISINUS0758871091
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$51.53bn
- Employees72,000
- ExchangeNew York Stock Exchange
- IndexS&P 500, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.